M1CK34 Stock Overview
Provides healthcare services in the United States and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 4/6 |
| Past Performance | 2/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
McKesson Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$900.90 |
| 52 Week High | US$917.10 |
| 52 Week Low | US$543.24 |
| Beta | 0.44 |
| 11 Month Change | 24.26% |
| 3 Month Change | 16.08% |
| 1 Year Change | n/a |
| 33 Year Change | 189.17% |
| 5 Year Change | n/a |
| Change since IPO | 467.67% |
Recent News & Updates
Recent updates
Shareholder Returns
| M1CK34 | BR Healthcare | BR Market | |
|---|---|---|---|
| 7D | -1.1% | -3.4% | -0.8% |
| 1Y | n/a | -18.9% | -2.4% |
Return vs Industry: Insufficient data to determine how M1CK34 performed against the BR Healthcare industry.
Return vs Market: Insufficient data to determine how M1CK34 performed against the BR Market.
Price Volatility
| M1CK34 volatility | |
|---|---|
| M1CK34 Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 5.9% |
| Market Average Movement | 4.6% |
| 10% most volatile stocks in BR Market | 8.2% |
| 10% least volatile stocks in BR Market | 2.4% |
Stable Share Price: M1CK34's share price has been volatile over the past 3 months compared to the BR market.
Volatility Over Time: Insufficient data to determine M1CK34's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1833 | 48,000 | Brian Tyler | www.mckesson.com |
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International.
McKesson Corporation Fundamentals Summary
| M1CK34 fundamental statistics | |
|---|---|
| Market cap | R$471.88b |
| Earnings (TTM) | R$15.05b |
| Revenue (TTM) | R$1.96t |
31.4x
P/E Ratio0.2x
P/S RatioIs M1CK34 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| M1CK34 income statement (TTM) | |
|---|---|
| Revenue | US$330.19b |
| Cost of Revenue | US$317.29b |
| Gross Profit | US$12.89b |
| Other Expenses | US$10.36b |
| Earnings | US$2.54b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 19.98 |
| Gross Margin | 3.90% |
| Net Profit Margin | 0.77% |
| Debt/Equity Ratio | -208.9% |
How did M1CK34 perform over the long term?
See historical performance and comparisonDividends
0.5%
Current Dividend Yield13%
Payout RatioDoes M1CK34 pay a reliable dividends?
See M1CK34 dividend history and benchmarks| McKesson dividend dates | |
|---|---|
| Ex Dividend Date | Nov 29 2024 |
| Dividend Pay Date | Jan 08 2025 |
| Days until Ex dividend | 1 day |
| Days until Dividend pay date | 41 days |
Does M1CK34 pay a reliable dividends?
See M1CK34 dividend history and benchmarks